ResearcherCentre National de la Recherche ScientifiqueNo recent work listed
Célia Cintas
Matched on ORCID iD 0000-0001-8730-9171; OpenAlex author ID A5016942889. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper
Papers 6
- A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids. Co-author DOI 10.1038/s41563-021-01085-1↗
- Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance. Co-author DOI 10.1158/1535-7163.mct-20-0981↗
- Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. Co-author DOI 10.15252/emmm.202013502↗
- Opportunities and Resistance to Signal-targeted Therapies in Pancreatic Cancer: What Can We Learn from Proteomic Studies? Co-author DOI 10.20944/preprints201802.0011.v1↗
- Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. Co-author DOI 10.3390/cancers10060174↗
- Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter? First author DOI 10.1016/j.jbior.2015.05.001↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Julie Guillermet‐Guibert · 5 shared papers, 2015–2021 · strength 0.49
- Paper Opportunities and Resistance to Signal-targeted Therapies in Pancreatic Cancer: What Can We Learn from Proteomic Studie… DOI 10.20944/preprints201802.0011.v1↗
- Paper Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistan… DOI 10.1158/1535-7163.mct-20-0981↗
- Paper Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. DOI 10.15252/emmm.202013502↗
- Nicole Therville · 4 shared papers, 2015–2021 · strength 0.36
- Paper Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistan… DOI 10.1158/1535-7163.mct-20-0981↗
- Paper Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. DOI 10.15252/emmm.202013502↗
- Paper Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. DOI 10.3390/cancers10060174↗
- Benoît Thibault · 3 shared papers, 2018–2021 · strength 0.28
- Paper Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistan… DOI 10.1158/1535-7163.mct-20-0981↗
- Paper Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. DOI 10.15252/emmm.202013502↗
- Paper Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. DOI 10.3390/cancers10060174↗
- Coralie Cayron · 2 shared papers, 2021 · strength 0.20
- Céline Basset · 2 shared papers, 2018–2021 · strength 0.18
- Romain Baer · 2 shared papers, 2015–2021 · strength 0.17
- Claus Jørgensen · 1 shared paper, 2022 · strength 0.11
- Derek A O'Reilly · 1 shared paper, 2022 · strength 0.11
- Jonathan D. Humphries · 1 shared paper, 2022 · strength 0.11
- Christopher Below · 1 shared paper, 2022 · strength 0.11
- Brian Yong Lee · 1 shared paper, 2022 · strength 0.11
- Martin James Humphries · 1 shared paper, 2022 · strength 0.11
- Jennifer P. Morton · 1 shared paper, 2022 · strength 0.11
- Zahra Dantes · 1 shared paper, 2021 · strength 0.10
- Paola Cappello · 1 shared paper, 2021 · strength 0.10
- Maximilian Reichert · 1 shared paper, 2021 · strength 0.10
- Fabrice Muscari · 1 shared paper, 2021 · strength 0.09
- Chiara Falcomatà · 1 shared paper, 2021 · strength 0.09
- Gabriela Reyes‐Castellanos · 1 shared paper, 2021 · strength 0.09
- Pierre Cordelier · 1 shared paper, 2021 · strength 0.09
- Barbara Bournet · 1 shared paper, 2021 · strength 0.09
- Alice Carrier · 1 shared paper, 2021 · strength 0.09
- Dieter Saur · 1 shared paper, 2021 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.